Literature DB >> 15950698

Hybrid constructs.

Rudolf Bertagnoli1, Patrick Tropiano, Jack Zigler, Armin Karg, Sandra Voigt.   

Abstract

Hybrid constructs can combine motion-preserving technologies with each other or motion-preserving technologies with fusion techniques. Hybrid constructs can be implanted in single-stage or multistage surgeries. Early results are promising. Further study under formal scientific conditions is necessary to explore the benefit of these combinations.

Mesh:

Year:  2005        PMID: 15950698     DOI: 10.1016/j.ocl.2005.03.002

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  6 in total

1.  Segment-by-segment stabilization for degenerative disc disease: a hybrid technique.

Authors:  Othmar Schwarzenbach; Nathalie Rohrbach; Ulrich Berlemann
Journal:  Eur Spine J       Date:  2010-02-04       Impact factor: 3.134

2.  Single and Multilevel Lumbar Total Disc Replacement Adjacent to L5-S1 ALIF (Lumbar Hybrid): 6 Years of Follow-up.

Authors:  Jason M Cuellar; Alexandre Rasouli; Todd H Lanman; Lea Kanim; Rick Delamarter
Journal:  Int J Spine Surg       Date:  2021-10-08

3.  Hybrid construct for two levels disc disease in lumbar spine.

Authors:  Stephane Aunoble; Robert Meyrat; Yasser Al Sawad; C Tournier; Philip Leijssen; Jean-Charles Le Huec
Journal:  Eur Spine J       Date:  2009-11-04       Impact factor: 3.134

Review 4.  [Surgical management of adult scoliosis. The challenge of osteoporosis and adjacent level degeneration].

Authors:  M Quante; A Richter; B Thomsen; M Köszegvary; H Halm
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

5.  We Need to Talk about Lumbar Total Disc Replacement.

Authors:  Stephen Beatty
Journal:  Int J Spine Surg       Date:  2018-08-03

6.  Novel indication for posterior dynamic stabilization: Correction of disc tilt after lumbar total disc replacement.

Authors:  Wayne K Cheng; Daniel Kyle Palmer; Vikram Jadhav
Journal:  SAS J       Date:  2011-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.